FDA approves emergency use of Sinopharm vaccine

enablePagination: false
maxItemsPerPage: 10
totalITemsFound:
maxPaginationLinks: 10
maxPossiblePages:
startIndex:
endIndex:

Metro Manila (CNN Philippines, June 7) – The country's Food and Drug Administration on Monday allowed the emergency use of COVID-19 vaccines made by Chinese manufacturer Sinopharm.

FDA Director General Eric Domingo confirmed the development to President Rodrigo Duterte during the weekly Inter-Agency Task Force for the Management of Emerging Infectious Diseases meeting.

"Today we already granted an emergency use authorization to DOH (Department of Health) to accept the donations of Sinopharm," said Domingo.

Sinopharm was the vaccine dose administered to Duterte last May 3

It was also the vaccine used to inoculate Duterte's close-in security group after the FDA granted a compassionate special permit in February

Domingo said during the President's May 27 televised meeting that it was the DOH that applied for Sinopharm's emergency use authorization in the Philippines. 

Sinopharm is the seventh vaccine manufacturer in the country to get regulatory approval after Sinovac, Pfizer-BioNTech, Oxford-AstraZeneca, Gamaleya-Sputnik V, Johnson & Johnson, and Moderna.

Last May 8, the World Health Organization authorized the emergency use of Sinopharm.